Poly-L-lactic Acid Filler Market To Reach $764.8 Million By 2030

Poly-L-lactic Acid Filler Market Growth & Trends

The global poly-l-lactic acid filler market size is expected to reach USD 764.8 million by 2030, registering a CAGR of 10.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The primary factors driving the market growth are the rising demand for minimally invasive cosmetic procedures, the growing aging population, and technological advancements. According to the ASPS article published in September 2023, there has been a notable rise in the number of male patients pursuing minimally invasive cosmetic surgeries, with over 1.5 million men undergoing these procedures in 2022. This marks a 253 percent increase since 2019. These aspects fuel the growth of the market.

Moreover, technological advancements of poly-l-lactic acid (PLLA) filler is anticipated to boost the market growth. According to the NCBI article published in June 2022, initially approved for correcting nasolabial folds and other facial wrinkles, PLLA fillers are now also used off-label for body rejuvenation. This broader application highlights the flexibility of PLLA fillers, which can address various aesthetic issues beyond the face, such as volume loss, skin laxity, and wrinkles in different body areas, including the neck. A significant technological advancement of PLLA fillers is their capacity to stimulate collagen production, resulting in long-term aesthetic benefits. Research indicates an increase in collagen type-I at 3 and 6 months post-PLLA injections, establishing PLLA fillers as a distinct class of collagen stimulators with prolonged effects. This characteristic makes PLLA fillers popular for their ability to deliver lasting skin quality and volume improvements.

The growing adoption of PLLA fillers among healthcare professionals and patients fuels market growth. According to the NCBI article published in March 2024, scientific research has confirmed the effectiveness of PLLA fillers, which stimulate collagen production and are gradually broken down into carbon dioxide and water. Even after the PLLA fully degrades, the newly formed collagen fibers can continue to function for an extended period, highlighting the fillers' long-lasting benefits and safety.

 Request a free sample copy or view report summary: Poly-L-lactic Acid Filler Market Report

Poly-L-lactic Acid Filler Market Report Highlights

• The face segment held the largest share, over 43.8%, in 2023, owing to the rising popularity of facial rejuvenation procedures, technological advancements in fillers, and the expanding middle-aged and elderly population.

• The cosmetic surgery centers segment held the largest share, 44.6%, in 2023 due to the presence of a higher number of these centers offering invasive procedures

• North America dominated the global market with a revenue share of 36.9% in 2023, owing to advanced healthcare infrastructure, increasing adoption of aesthetic procedures, huge research and development activities, and continuous technological advancements in cosmetic treatments.

Poly-L-lactic Acid Filler Market Segmentation

Grand View Research has segmented the global poly-l-lactic acid (PLLA) filler market based on application, end use, and region:

Poly-L-lactic Acid (PLLA) Filler Application Outlook (Revenue, USD Million, 2018 - 2030)

• Face

• Neck

• Abdomen

• Knees

• Thighs

• Others

Poly-L-lactic Acid (PLLA) Filler End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Medspas

• Cosmetic Surgery Centers

• Others

Poly-L-lactic Acid (PLLA) Filler Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Thailand

  • South Korea

  • Australia

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Poly-L-lactic Acid Filler Market

• Galderma

• GANA R&D

• Sinclair Pharma

• PRP Science

• EPRUI Biotech

• Hyamax